These final results, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the concept of targeting ACKR3 as a singular approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Conditions. Long-term pain is elaborate, https://hanness138smg6.wikiconversation.com/user